{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:30:41Z","timestamp":1758040241135,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.amjcard.2020.07.053","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T21:30:23Z","timestamp":1595885423000},"page":"77-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bretylium, a Class III Antiarrhythmic, Returns to the Market"],"prefix":"10.1016","volume":"133","author":[{"given":"Munveer","family":"Thind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-5223","authenticated-orcid":false,"given":"Renee M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard N.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.07.053_bib0001","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0002","unstructured":"Determination that Bretylium Tosylate Injection, 50 Milligrams\/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register \/ Vol. 76, No. 243 \/ Monday, December 19, 2011 \/ Notices. 78699-78670. https:\/\/www.federalregister.gov\/documents\/2011\/12\/19\/2011-32367\/determination-that-bretylium-tosylate-injection-50-milligramsmilliliter-was-not-withdrawn-from-sale."},{"key":"10.1016\/j.amjcard.2020.07.053_bib0003","article-title":"Part 6: advanced cardiovascular life support section 1: introduction to ACLS 2000: overview of recommended changes in ACLS from the guidelines 2000 conference originally published 22 Mar 2018","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-91-2-229","article-title":"Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias","volume":"91","author":"Heissenbuttel","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0005","unstructured":"Vaughan Williams EM Classification of antiarrhythmic drugs. E Sandoe, E Flensted-Jensen, K Olesen, eds. Symposium Cardiac Arrhythmias. Stockholm, Sweden Astra1970;449-472."},{"key":"10.1016\/j.amjcard.2020.07.053_bib0006","unstructured":"Package insert Bretylium Tosylate https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=b5b9b1de-d819-4e49-ac0b-05b29033df1c."},{"key":"10.1016\/j.amjcard.2020.07.053_bib0007","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.amjcard.2020.02.010","article-title":"The bretylium saga: a novel \u201cold drug\u201d for cardiac resuscitation","volume":"125","author":"Bacaner","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0008","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0196-0644(81)80306-X","article-title":"Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo","volume":"10","author":"Nowak","year":"1981","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0196-0644(84)80469-2","article-title":"Treatment of prehospital refractory ventricular fibrillation with bretylium tosylate","volume":"13","author":"Stang","year":"1984","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9149(81)90619-6","article-title":"Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial","volume":"48","author":"Haynes","year":"1981","journal-title":"Am J Cardiol"},{"issue":"9 Pt 2","key":"10.1016\/j.amjcard.2020.07.053_bib0011","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0196-0644(84)80444-8","article-title":"A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system","volume":"13","author":"Olson","year":"1984","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0012","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1161\/01.CIR.92.11.3255","article-title":"Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group","volume":"92","author":"Kowey","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.mjt.0000126444.24163.81","article-title":"Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?","volume":"11","author":"Bacaner","year":"2004","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0014","first-page":"901","article-title":"[The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction]","volume":"47","author":"Kochma\u0144ski","year":"1992","journal-title":"Pol Tyg Lek"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0015","doi-asserted-by":"crossref","first-page":"20A","DOI":"10.1016\/0002-9149(84)90813-0","article-title":"Bretylium tosylate in patients with acute myocardial infarction","volume":"54","author":"Torresani","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0016","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0017","first-page":"1329","article-title":"PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","volume":"38","author":"Ortiz","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.07.053_bib0018","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1161\/CIR.0000000000000613","volume":"138","author":"Panchal","year":"2018","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920307888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920307888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:35:25Z","timestamp":1757572525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920307888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":18,"alternative-id":["S0002914920307888"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.07.053","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bretylium, a Class III Antiarrhythmic, Returns to the Market","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.07.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}